TrialDiabetes, obesity & metabolism2018
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy.
Tina Vilsbøll et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
127 papers cite itlatest 60 shown
this paperpooled ittrialcites it